Results 171 to 180 of about 54,840 (264)

Trajectories of Physical Function in Canadian Children With Juvenile Idiopathic Arthritis

open access: yesArthritis Care &Research, Volume 78, Issue 10, Page 1564-1573, October 2026.
Objective We describe trajectories of physical function in children newly diagnosed with juvenile idiopathic arthritis (JIA) and identify trajectories with persisting functional impairments and associated baseline characteristics. Methods We included patients enrolled in the Canadian Alliance of Pediatric Rheumatology Investigators (CAPRI) Registry ...
Clare Cunningham   +81 more
wiley   +1 more source

A hybrid RNA-based reporter assay for robust quantification of cytidine deaminase activity. [PDF]

open access: yesNucleic Acids Res
Ligasová A   +5 more
europepmc   +1 more source

Cardiovascular Toxicity Associated With Bispecific Antibodies in Hematological Malignancies: A Comprehensive Pharmacovigilance Analysis

open access: yesAmerican Journal of Hematology, Volume 101, Issue 10, Page 2546-2556, October 2026.
ABSTRACT Cardiovascular adverse events (CVAEs) associated with bispecific T‐cell engaging antibodies (BsAbs) have not been systematically investigated across approved agents. In this disproportionality analysis of FAERS (December 2014–September 2025), reports listing BsAbs as the primary suspected drug (n = 7647) were compared with all other drugs in ...
Malak Munir   +9 more
wiley   +1 more source

Long‐Term Expansion, Ecosystem Services and Management Trade‐Offs of Phragmites karka in Asia's Largest Lagoon

open access: yesAquatic Conservation: Marine and Freshwater Ecosystems, Volume 36, Issue 10, October 2026.
ABSTRACT Coastal lagoons are increasingly altered by hydrological modification and catchment‐derived nutrient loading, driving shifts in macrophyte dominance and creating complex management trade‐offs. In Chilika lagoon, India, the emergent macrophyte Phragmites karka has expanded, raising concerns about impacts on native macrophytes, habitat ...
Anjalis Mishra   +3 more
wiley   +1 more source

Pharmacogenomic profiling of the efficacy of gemcitabine monotherapy in metastatic pancreatic cancer: Subgroup analysis of the GENESECT study

open access: yesBritish Journal of Clinical Pharmacology, Volume 92, Issue 10, Page 3397-3406, October 2026.
Aim In the GENESECT study, no significant gemcitabine (GEM) metabolism‐related germline genetic polymorphisms (GPs) were identified because approximately 70% of patients received combination therapy with nab‐paclitaxel, which has metabolic pathways different from GEM.
Takashi Yokokawa   +21 more
wiley   +1 more source

Home - About - Disclaimer - Privacy